Ilsung Pharmaceuticals Co., Ltd.

KSE 003120.KS

Ilsung Pharmaceuticals Co., Ltd. Dividend Per Share for the year ending December 31, 2023: USD 3.26

Ilsung Pharmaceuticals Co., Ltd. Dividend Per Share is USD 3.26 for the year ending December 31, 2023, a 13,299.20% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.

Ilsung Pharmaceuticals Co., Ltd. Dividend Per Share for the year ending December 31, 2022 was USD 0.02, a -80.64% change year over year.
Ilsung Pharmaceuticals Co., Ltd. Dividend Per Share for the year ending December 31, 2021 was USD 0.13, a -8.82% change year over year.
Ilsung Pharmaceuticals Co., Ltd. Dividend Per Share for the year ending December 31, 2020 was USD 0.14, a 9.59% change year over year.
Ilsung Pharmaceuticals Co., Ltd. Dividend Per Share for the year ending December 31, 2019 was USD 0.13, a -6.30% change year over year.

Key data

Date	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)

KSE: 003120.KS

Ilsung Pharmaceuticals Co., Ltd.

CEO	Mr. Seok-geun Yoon
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	84-gil 9, Wonhyo-ro
Employees	224
Sector	Health Care
Industries Pharmaceuticals

Description

Ilsung Pharmaceuticals Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, anti-coagulants, circulatory system drugs, contrast agents, diabetes treatments, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, anesthetics, antipyretics, and cardiovascular system products. Ilsung Pharmaceuticals Co., Ltd. was founded in 1954 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years